Introduction

Symptoms of neurogenic bowel dysfunction (NBD) are among of the most troublesome problems facing subjects with spinal cord injury (SCI). Difficult bowel emptying is a prominent symptom.1 The pathophysiological effect on bowel function depends on lesion level. Subjects with supraconal SCI generally have prolonged colonic transit, whereas those with conal and cauda equina lesions primarily have rectosigmoid impaction.2 Supraconal injuries result in a hypertone and hyperreactive rectosigmoid wall, reversely for conal and cauda equina injuries.3 Therefore, results obtained among subjects with conal and cauda equina lesions are not directly applicable to lesions at higher levels.

Quantification of intraluminal transport at defecation in supraconal SCI has never been performed. A direct measurement is possible when stools are marked with orally taken radioactive isotopes followed by colorectal scintigraphy before and after defecation.

The standard method for objective evaluation of colorectal or gastrointestinal transit time (GITT) is oral intake of radiopaque markers followed by one or more plain abdominal X-rays.4 This method is also followed for SCI,2, 5, 6 but there is no correlation between subject-reported symptoms of NBD and colorectal transit time or GITT assessed by radiopaque markers.5

Based on this, we hypothesized that subjects with supraconal SCI have reduced colorectal transport at defecation. Accordingly, we aimed at comparing colorectal transport and bowel emptying during defecation in subjects with supraconal SCI and healthy volunteers. Further, we aimed at investigating possible correlations between transport at defecation and symptoms of NBD and GITT.

Materials and methods

Subjects eligible for inclusion were identified via file review in our neurosurgical department (Figure 1). Inclusion criteria were first hospital admission with SCI between 1 January 1989 and 1 May 2010, injury corresponding to the American Spinal Injury Association impairment scale (AIS) A–D at present investigation, SCI level at C4–L4 segment and 18 years of age. Exclusion criteria were previous major gastrointestinal surgery and concomitant disease affecting gastrointestinal function. Because of the irradiation dose associated with this study, subjects with earlier irradiation towards the abdominal cavity or exposure to radiation >5 mSv above the background irradiation within the last year were not invited to participate.

Figure 1
figure 1

Flowchart of subject inclusion.

Bowel function scores

Information about bowel symptoms and current medication in SCI subjects was collected using the international bowel function basic and extended SCI data set with a few additional questions.7, 8 Based on this information, the NBD score,9 the St Mark’s incontinence score10 and the Cleveland constipation score11 were calculated for each subject.

Gastrointestinal transit time

The method and data analysis are commonly used in other studies.4 Thereby, all SCI subjects took 10 radiopaque markers on 6 consecutive days. On day 7, a whole abdominal X-ray was taken and GITT was calculated from the total number of markers present.

Scintigraphic procedure

Scintigraphic assessment of colorectal transport and bowel emptying during normal defecation has been described in detail by Krogh et al.12 Data from 16 of those healthy volunteers describing normal defecation in the previous study were used for comparison with SCI subjects in this study.

Subjects took 111In-coated resin pellets in 100 ml of water for 2 days. To ensure marking of all colorectal content, subjects with GITT 2.5 days took 111In-coated resin pellets 48 and 24 h before the study. If GITT >2.5 days, the 111In-coated resin pellets were taken 72 and 24 h before the study. All medication affecting gastrointestinal function, including Baclofen, was paused 24 h before the scintigram.

All investigations were performed at 0800 hours after an overnight fast and without subjects having defecated in the morning. Scintigraphy was performed before and after subjects had emptied their bowel using their normal bowel-emptying procedures. Subject had a standardized breakfast just after the first scintigraphy and before bowel emptying to activate the gastrocolonic response.

Scintigraphy was performed using a double-headed Picker Axis gamma camera with parallel-hole, medium-energy collimators imaging the whole abdomen, with subjects lying flat on their back. The acquisition time was 10 min (five 2-min frames). Anterior and posterior images were obtained using 20% energy windows over the 174-keV and 247-keV 111In photopeaks, respectively.

Computation of colorectal transport at defecation

The number of counts in each segment was determined before and after bowel emptying. The colorectum was divided into four segments for analysis: the cecum and ascending colon including the right flexure, the transverse colon, the descending colon including the left flexure and the rectosigmoid.10 Correction for tissue attenuation was carried out by calculating the geometric mean (square root of each segment’s anterior and posterior counts before and after defecation, respectively).13 Data were discarded if segments were overlapping in the scintigraphic frames making delineation of the segments impossible or if counts in the rectosigmoid were >7.5% of the total counts prior to defecation.

Accordingly, defecation score and antegrade and retrograde segmental transport can be calculated as described in detail in an earlier publication.14 Briefly, a defecation score of 40 corresponds to emptying 40% of the content in the rectosigmoid during defecation and 150 corresponds to 100% emptying of the rectosigmoid and 50% emptying of the descending colon. A maximum of 400 can be achieved, meaning all colonic content is lost at defecation. We calculated antegrade and retrograde transport from each segment. The transport is given in percentage of the content of the specific segment prior to defecation and is used in addition to the defecation score to describe movement within the colorectum at defecation.

Statistical analysis

Data analysis was performed using the statistical program STATA 12. Results were compared between healthy volunteers and SCI subjects using the Wilcoxon–Mann–Whitney test for statistical significance level. Associations between defecation score, symptom scores and GITT were tested with Spearman’s rank correlation. Statistical significance was defined as P<0.05. Results are given as median and range.

Ethical considerations

The total whole-body effective radiation dosage was 1.1–3.1 mSv, depending on the individual GITT. The study was performed according to the Declaration of Helsinki II and approved by the local ethics committee for the Central Denmark Region (project no. M-20100299). We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this study.

Results

Out of 21 subjects with SCI, six were excluded due to overlapping colonic segments (n=1), lack of defecation on the day of investigation (n=1) and <7.5% of total counts in the rectosigmoid segment prior to defecation (n=4). Thus, 15 SCI subjects went on to further analysis (Figure 1). Patients were classified according to the International Standards for Classification of Spinal Cord Injuries.15 For comparison, 16 healthy volunteers were used. Table 1 describes detailed subject demographics.

Table 1 Display of subject demographics

Colorectal emptying during defecation

Examples of scintigrams from a subject with SCI and a healthy volunteer before and after defecation are shown in Figure 2. In SCI subjects, the median defecation score was 31 (range: 0–149), corresponding to 31% emptying of the rectosigmoid during defecation, and in healthy volunteers, it was 89 (range: 53–203), corresponding to 89% emptying of the rectosigmoid (P<0.01). No association could be found to age (P=0.10), AIS score (P=0.82), time between SCI and investigation (P=0.47) and SCI level (P=0.94).

Figure 2
figure 2

Colorectal scintigraphy before (a and c) and after (b and d) defecation for (a and b, at the top) an SCI subject and (c and d, below) a healthy volunteer. As illustrated, a large proportion of the fecal matter in the descending colon and rectosigmoid is emptied during defecation by the healthy volunteer but not by the subject with SCI.

Segmental colorectal transport at defecation

Comparing subjects with SCI and healthy volunteers, median antegrade transport was 5% (range: 0–25%) vs 4% (range: 0–39%), P=0.90, from the ascending colon; 2% (range: 0–38%) vs 6% (range: 0–130%), P=0.47, from the transverse colon; 11% (range: 0–62%) vs 30% (range: 0–73%), P=0.05, from the descending colon and 31% (range: 0–194%) vs 82% (range: 53–203%), P<0.01, from the rectosigmoid. As illustrated in Figure 3, antegrade segmental transport was more affected by SCI in the distal than in the proximal part of the colorectum.

Figure 3
figure 3

Display of the impaired bowel movement for the supraconal SCI subjects compared with healthy volunteers. Colorectal region of interest is displayed on the x axis and percentage of predefecational content on the y axis. Impairment tends to increase as bowel content moves in anal direction. Primary impairment is seen in the left side of the colon (descending and rectosigmoid segments).

Median retrograde transport showed no difference between subjects with SCI and controls as it was 0% (range: 0–5%) vs 0% (range: 0–36%), P=0.63, from the transverse colon; 0% (range: 0–5%) vs 0% (range: 0–25%), P=0.64, from the descending colon and 0% (range: 0–21%) vs 0% (range: 0–41%), P=0.57, from the rectosigmoid.

GITT and segmental colonic transit times

Among SCI subjects, median GITT was 2.9 days (range: 1.5–5.8 days), whereas transit time was 0.6 days (range: 0.1–3.4 days) through the ascending colon, 0.2 days (range: 0.0–2.2 days) through the transverse colon, 0.5 days (range: 0.0–1.7 days) through the descending colon and 0.4 days (range: 0.0–1.7 days) through the rectosigmoid. No correlation could be found between the scintigraphic defecation score and GITT (P=0.99).

Bowel symptoms

In SCI subjects, the median NBD score was 10 (range: 3–23), corresponding to moderate bowel dysfunction. The median St Mark’s fecal incontinence score was 4 (range: 0–10), and the median Cleveland constipation score was 6 (range: 4–13). The scintigraphic defecation score was associated with the St Mark’s fecal incontinence score (P=0.02) but not with the NBD score (P=0.12) and the Cleveland constipation score (P=0.17). GITT was not associated with the St Mark’s fecal incontinence score (P=0.53), the NBD score (P=0.83) or the Cleveland constipation score (P=0.84).

Discussion

We have demonstrated that subjects with supraconal SCI have significantly reduced emptying of the colorectum at defecation. Normal defecation usually includes emptying the majority of the rectosigmoid and some antegrade transport from the transverse and descending colon.14 It is usually preceded by colonic mass movements that bring stools to the rectum. Distension of the rectal wall may further stimulate colorectal contractions by an intrinsic reflex mediated by the enteric nervous system and the parasympathetic defecation reflex involving spinal segments S2–S4. Rectal filling stretches the rectal wall and stimulates the rectoanal inhibitory reflex, relaxing the internal anal sphincter muscle. The rectoanal inhibitory reflex is intrinsic but probably enhanced by parasympathetic stimuli from S2 to S4. The defecation process is supported by a Valsalva maneuver.

Normal defecation physiology relies on intact neuromuscular control. Therefore, hampered evacuation and constipation-related symptoms are linked to SCI.1 There are, however, fundamental differences depending on the level of injury. Supraconal lesions result in increased colorectal tone and contractility,6, 16 whereas conal and cauda equina lesions cause a hypotone and hyporeflex left colon and rectum.2 The rectoanal inhibitory reflex facilitating defecation is blunted in subjects with conal or cauda equina lesions but not in those with supraconal lesions. Accordingly, subjects with supraconal lesions in general have prolonged transit throughout the colon but less severely prolonged rectosigmoid passage. In contrast, subjects with conal or cauda equina lesions mainly have severely prolonged transit through the distal colorectum.2, 12

These basic pathophysiological differences explain reduced emptying at defecation among subjects with conal/cauda equina lesions.12 The effect of supraconal SCI is less predictable. The hyperreactive rectal wall could ease digital stimulation and enhance the effect of suppositories or enemas, and bowel emptying is considered less difficult in supraconal than in conal/cauda equina lesions.17

In spite of this, data from this study clearly showed abnormally poor rectosigmoid emptying of stools in subjects with supraconal SCI. Further, antegrade segmental colorectal transport at defecation was significantly more pronounced in the distal than in the proximal parts. No difference was found in retrograde segmental transport. To what degree this is caused by reduced rectal compliance,18 rectoanal sphincter dyssynergia,19 blunted gastrocolonic response, loss of anorectal sensation or reduced abdominal muscle function remains to be investigated.

A study in a mixed population with multiple sclerosis and SCI has pointed towards an association between specific anorectal physiology markers and both the Wexner fecal incontinence score and Cleveland constipation scores,18 but anorectal physiology tests do not contribute much to the clinical evaluation of NBD. GITT is commonly used for evaluation of NBD in research and clinical practice. Unfortunately, there is no correlation between transit times and symptoms in subjects with SCI,5 and the present study could not find a correlation between the scintigraphic defecation score and GITT. This restricts the usefulness of GITT for clinical decision making.

It was our hope that colorectal scintigraphy would provide a valid alternative, also for clinical use. Even though data indicated a better correlation between symptoms and the scintigraphic defecation score than between symptoms and GITT, the only association reaching statistical significance was between the defecation score and the St Mark’s incontinence score. The lack of statistical significance to the NBD score and the Cleveland constipation score may be a type II error caused by the inclusion of too few subjects. We believe that associations between symptoms and scintigraphic evaluation of defecation should be investigated in a larger study.

The association between poor emptying at defecation and fecal incontinence as observed in this study indicates that rectosigmoid impaction may contribute to fecal incontinence in supraconal SCI. The other factors are lack of voluntary control of the external anal sphincter muscle and loss of anorectal sensation.19 Perhaps a wider-scale use of irrigation should be considered for supraconal SCI subjects.

The colorectal scintigraphy method has been used for in several studies since its introduction20 and holds promise as an objective end point in future studies evaluating new and existing treatment modalities for NBD. It allows very detailed computations of defecation and colonic content movements. Limitations for the use of the method are availability, irradiation of subjects, insufficient pellet distribution in all colorectal segments and, with some protocols, the need for defecation at a specific time. To ensure representation of all colonic segments, two doses of pellets were taken and administered according to individual GITT. In spite of this, we had to exclude six subjects. The large variation in GITT (2.1–6.6 days in this study) is another limitation with the use of the method.

Of a total 106 eligible subjects, 21 were included and data from 15 were used. This reflects the reality of clinical research. It might have introduced selection bias, and the relatively small numbers may have caused type II errors where differences could not be found. However, the substantial difference between SCI and controls found in the study would not be affected by the small numbers. The gender distribution was not the same in SCI subjects and controls. Some earlier studies have found a difference in GITT between males and females.4 This was, however, not the case with colorectal scintigraphy.14 Age difference is another possible bias. Deterioration in continence with increasing age has been demonstrated but not in SCI subjects.6 In able-bodied controls, the subjective evaluation of whether defecation had been normal or not reflected the degree of colorectal emptying at defecation.14 Among subjects with SCI, we did not find the same correlation, probably due to reduced or absent anorectal sensation.

In conclusion, subjects with supraconal SCI have impaired colorectal emptying at defecation. Abnormally low emptying at defecation was associated with severe fecal incontinence, suggesting that rectosigmoid fecal impaction contributes to incontinence.

Data archiving

There were no data to deposit.